Back to Agenda
Data Sharing and Secondary Use of Data
Session Chair(s)
Merete Joergensen, MBA, MSc
Clinical Disclosure and Transparency Expert, Former EFPIA, CREG Clinical Trials
Merete-J Consulting CVR: 34920818, Denmark
Transparency of clinical information and sharing of person level data has been increasing over the last couple of years. Views of the challenges as well as the benefits experienced will be shared. The aim of the session is to share views on how to make the best out of the efforts that are put into sharing the wealth of information.
Learning Objective : i. Describe current national and regional clinical trial transparency regulations and requirements ii. Compare models for coordinating and streamlining clinical trial transparency operations across clinical development platforms and functions iii. Apply concepts from best practices for cross-platform/functions collaboration for timely clinical trial transparency compliance.
Speaker(s)
Aligning Clinical Trial Transparency Operations with Clinical Development Programme
Oladayo Oyelola, PhD
Daiichi Sankyo, Inc. , United States
Senior Director and Head Clinical Trial Information Disclosure
Experience in Sharing Clinical Data for Secondary Use
Martin Schumacher
University of Freiburg, Germany
Professor, Institute for Medical Biometry and Statistics
Sharing of Individual Patient Data (IPD) – Data Utility Considerations
Ingeborg Cil, MSc
Xogene Gmbh, Austria
Lead, Clinical Trial Data Anonymization
Have an account?